These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

585 related items for PubMed ID: 33993888

  • 1. Effective treatment of electrical storm by a wearable cardioverter defibrillator in a patient with severely impaired left ventricular function after myocardial infarction: a case report.
    Andresen H, Sasko B, Patschan D, Pagonas N, Ritter O.
    J Med Case Rep; 2021 May 17; 15(1):243. PubMed ID: 33993888
    [Abstract] [Full Text] [Related]

  • 2. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.
    Epstein AE, Abraham WT, Bianco NR, Kern KB, Mirro M, Rao SV, Rhee EK, Solomon SD, Szymkiewicz SJ.
    J Am Coll Cardiol; 2013 Nov 19; 62(21):2000-2007. PubMed ID: 23916930
    [Abstract] [Full Text] [Related]

  • 3. Wearable cardioverter defibrillator after cardiac surgery: Analysis of real-life data from patients at transient risk of sudden cardiac death.
    Elbayomi M, Weyand M, Seitz T, Harig F.
    Ann Noninvasive Electrocardiol; 2023 Mar 19; 28(2):e13048. PubMed ID: 36723848
    [Abstract] [Full Text] [Related]

  • 4. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S, Rosenkaimer SL, Hohneck A, Lang S, El-Battrawy I, Rudic B, Tülümen E, Stach K, Kuschyk J, Akin I, Borggrefe M.
    BMC Cardiovasc Disord; 2018 Mar 15; 18(1):52. PubMed ID: 29544442
    [Abstract] [Full Text] [Related]

  • 5. The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital.
    Sinha AM, Bense J, Hohenforst-Schmidt W.
    J Interv Card Electrophysiol; 2021 Nov 15; 62(2):401-407. PubMed ID: 33200285
    [Abstract] [Full Text] [Related]

  • 6. [The wearable cardioverter defibrillator - temporary protection against sudden cardiac death].
    Almqvist M, Mattsson G, Magnusson P.
    Lakartidningen; 2019 Apr 16; 116():. PubMed ID: 31192401
    [Abstract] [Full Text] [Related]

  • 7. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU, Goldenberg I, Moss AJ.
    Eur Heart J; 2013 Aug 16; 34(29):2230-42. PubMed ID: 23729691
    [Abstract] [Full Text] [Related]

  • 8. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
    Duncker D, König T, Hohmann S, Bauersachs J, Veltmann C.
    J Am Heart Assoc; 2017 Jan 17; 6(1):. PubMed ID: 28096098
    [Abstract] [Full Text] [Related]

  • 9. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V, Moss AJ, Klein H, Biton Y, McNitt S, MacKecknie B, Zareba W, Goldenberg I.
    Circulation; 2015 Oct 27; 132(17):1613-9. PubMed ID: 26316618
    [Abstract] [Full Text] [Related]

  • 10. Usefulness of the wearable cardioverter-defibrillator in patients at high risk for sudden cardiac death.
    Sasaki S, Tomita H, Shibutani S, Izumiyama K, Higuma T, Itoh T, Sasaki K, Horiuchi D, Kimura M, Okumura K.
    Circ J; 2014 Oct 27; 78(12):2987-9. PubMed ID: 25366562
    [Abstract] [Full Text] [Related]

  • 11. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.
    Ellenbogen KA, Koneru JN, Sharma PS, Deshpande S, Wan C, Szymkiewicz SJ.
    JACC Clin Electrophysiol; 2017 Mar 27; 3(3):243-250. PubMed ID: 29759518
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients.
    Erath JW, Vamos M, Sirat AS, Hohnloser SH.
    Clin Res Cardiol; 2017 Apr 27; 106(4):300-306. PubMed ID: 27888304
    [Abstract] [Full Text] [Related]

  • 17. Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator.
    Zishiri ET, Williams S, Cronin EM, Blackstone EH, Ellis SG, Roselli EE, Smedira NG, Gillinov AM, Glad JA, Tchou PJ, Szymkiewicz SJ, Chung MK.
    Circ Arrhythm Electrophysiol; 2013 Feb 27; 6(1):117-28. PubMed ID: 23275233
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Potential roles of the wearable cardioverter-defibrillator in acute phase care of patients at high risk of sudden cardiac death: A single-center Japanese experience.
    Sasaki S, Shoji Y, Ishida Y, Kinjo T, Tsushima Y, Seno M, Nishizaki F, Itoh T, Izumiyama K, Yokota T, Yokoyama H, Yamada M, Horiuchi D, Kimura M, Higuma T, Tomita H, Okumura K.
    J Cardiol; 2017 Jan 27; 69(1):359-363. PubMed ID: 27595899
    [Abstract] [Full Text] [Related]

  • 20. A wearable cardioverter defibrillator with a low false alarm rate.
    Poole JE, Gleva MJ, Birgersdotter-Green U, Branch KRH, Doshi RN, Salam T, Crawford TC, Willcox ME, Sridhar AM, Mikdadi G, Beinart SC, Cha YM, Russo AM, Rowbotham RK, Sullivan J, Gustavson LM, Kivilaid K.
    J Cardiovasc Electrophysiol; 2022 May 27; 33(5):831-842. PubMed ID: 35174572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.